Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Auschwitz survivor among the first vaccinated in hometown of Pfizer’s CEO

Zana Sadikario-Saatsoglou, a Thessalonikan Jew and Holocaust survivor, became one of the first people in Greece to receive Pfizer’s coronavirus vaccine on Tuesday.

98-year-old Sadikario-Saatsoglou received the vaccine at Thessaloniki’s Saul Modiano Old Age Home, which serves its Jewish community. Greece received nearly 10,000 doses of the vaccine in late December and began rolling them out shortly after the new year, to the elderly and first responders.

Pfizer’s CEO, Albert Bourla, is also from Thessaloniki. His parents, like Sadikario-Saatsoglou, survived Auschwitz.

Before the war, Bourla’s ancestors were part of Thessaloniki’s large Jewish merchant class and traded jewelry, diamonds and other gems across the Balkans, according to the Central Board of Jewish Communities in Greece.

Thessaloniki was once one of the most Jewish cities in the world: nearly half its population of 118,000 was Jewish around the turn of the 20th century, according to Ottoman censuses. Jews had lived in the city as far back as biblical times. That came to an end in the years of Zana’s youth: in 1943, the city’s Jewish population was deported to Auschwitz.

She was among the few who returned.

During the war, 45,000 Jews from Thessaloniki were sent to Auschwitz, according the United States Holocaust Memorial Museum; 5,000 are believed to have survived. Overall, 81% of Greek Jewry were murdered by the Nazis, a death rate rivaled only by major European Jewish centers like Poland and Lithuania.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version